Heart retransplantation

American Journal of Transplantation

Volumn 7, Issue 9, 2007, Pages 2075-2081

  Johnson, M R ^a   Aaronson, K D ^b   Canter, C E ^c   Kirklin, J K ^d   Mancini, D M ^e   Mehra, M R ^f   Radovancevic, B ^g   Taylor, D O ^h   Webber, S A ⁱ  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c ST LOUIS CHILDREN S HOSPITAL   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e Columbia University College of Physicians and Surgeons ^*  (United States)

^f UNIVERSITY OF MARYLAND   (United States)

^g TEXAS HEART INSTITUTE   (United States)

^h LERNER RESEARCH INSTITUTE   (United States)

ⁱ CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Cardiac allograft vasculopathy; Heart transplantation; Retransplant

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; EVEROLIMUS; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PRAVASTATIN; RAPAMYCIN; SIMVASTATIN;

CARDIAC GRAFT REJECTION; CHRONIC GRAFT REJECTION; CONSENSUS; DISEASE COURSE; DISEASE SEVERITY; DRUG SUBSTITUTION; ETHICS; GRAFT FAILURE; GRAFT SURVIVAL; HALF LIFE TIME; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HEART TRANSPLANTATION; HEMODYNAMICS; HUMAN; INCIDENCE; INFECTION; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETRANSPLANTATION; RISK FACTOR; SHORT SURVEY; SYMPTOMATOLOGY; TREATMENT INDICATION; VASCULAR DISEASE;

GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; PROGNOSIS; REOPERATION;

EID: 34547842725     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2007.01902.x     Document Type: Short Survey

References (25)

1. Magee JC, Barr ML, Basadonna GP et al. Repeat organ transplantation in the United States, 1996-2005. Am J Transplant 2007 7(Part 2):1424 1433.
2. Ensley RD, Hunt S, Taylor DO et al. Predictors of survival after repeat heart transplantation. J Heart Lung Transplant 1992 11:S142 S158.
3. Taylor DO, Edwards LB, Boucek MM et al. Registry of the International Society for Heart and Lung Transplantation: Twenty-Second Official Adult Heart Transplant Report - 2005. J Heart Lung Transplant 2005 24:945 955.
4. Srivastava R, Keck BM, Bennett LE, Hosenpud JD. The results of cardiac retransplantation: An analysis of the Joint International Society for Heart and Lung Transplantation/United Network for Organ Sharing Thoracic Registry. Transplantation 2000 70:606 612.
5. Radovancevic B, McGiffin DC, Kobashigawa JA et al. Retransplantation in 7,290 primary transplant patients: A 10-year multi-institutional study. J Heart Lung Transplant 2003 22:862 868.
6. Topkara VK, Dang NC, John R et al. A decade experience of cardiac retransplantation in adult recipients. J Heart Lung Transplant 2005 24:1745 1750.
7. Schnetzler B, Pavie A, Dorent R et al. Heart retransplantation: A 23-year single-center clinical experience. Ann Thorac Surg 1998 65:978 983.
8. Karwande SV, Ensley RD, Renlund DG et al. Cardiac retransplantation: A viable option? Ann Thorac Surg 1992 54:840 845.
9. Schlechta B, Kocher AA, Ehrlich M et al. Heart retransplantation: Institutional results of a series of 31 cases. Transplant Proc 2001 33:2759 2761.
10. Smith JA, Ribakove GH, Hunt SA et al. Heart retransplantation: The 25-year experience at a single institution. J Heart Lung Transplant 1995 14:832 839.
11. John R, Chen JM, Weinberg A et al. Long-term survival after cardiac retransplantation: A twenty-year single-center experience. J Thorac Cardiovasc Surg 1999 117:543 555.
12. Boucek MM, Edwards LB, Keck BM, Trulock EP, Taylor DO, Hertz MI. Registry of the International Society for Heart and Lung Transplantation: Eighth Official Pediatric Report - 2005. J Heart Lung Transplant 2005 24:968 982.
13. Mahle WT, Vincent RN, Kanter KR. Cardiac retransplantation in childhood: Analysis of data from the United Network for Organ Sharing. J Thorac Cardiovasc Surg 2005 130:542 546.
14. Almond CS, Blume ED, Edwards LB, Boucek MM. Risk factors for mortality following pediatric heart retransplantation: Analysis from the International Society of Heart and Lung Transplantation Registry (abstract). J Heart Lung Transplant 2006 25:S51.
15. Chin C, Naftel D, Pahl E et al. Cardiac re-transplantation in pediatrics: A multi-institutional study. J Heart Lung Transplant 2006 25:1420 1424.
16. Kanter KR, Vincent RN, Berg AM, Mahle WT, Forbess JM, Kirshbom PM. Cardiac retransplantation in children. Ann Thorac Surg 2004 78:644 649.
17. Dearani JA, Razzouk AJ, Gundry SR et al. Pediatric cardiac retransplantation: Intermediate-term results. Ann Thorac Surg 2001 71:66 70.
18. Michler RE, Edwards NM, Hsu D et al. Pediatric retransplantation. J Heart Lung Transplant 1993 12 (6 Pt 2 S319 S327.
19. Costanzo MR, Naftel DC, Pritzker MR et al. Heart transplant coronary artery disease detected by coronary angiography: A multiinstitutional study of preoperative donor and recipient risk factors. J Heart Lung Transplant 1998 17:744 753.
20. Mancini D, Pinney S, Burkhoff, D et al. Use of rapamycin slows progression of cardiac transplantation vasculopathy. Circulation 2003 108:48 53.
21. Eisen HJ, Kobashigawa J, Keogh A et al. Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients. J Heart Lung Transplant 2005 24:517 525.
22. Keogh A, Richardson M, Ruygrok P et al. Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: A randomized clinical trial. Circulation 2004 110:2694 2700.
23. Eisen HJ, Tuzcu EM, Dorent R et al. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med 2003 349:847 858.
24. Kobashigawa JA, Moriguchi JD, Laks H et al. Ten-year follow-up of a randomized trial of pravastatin in heart transplant patients. J Heart Lung Transplant 2005 24:1736 1740.
25. Wenke K, Meiser B, Thiery J et al. Simvastatin initiated early after heart transplantation: 8-year prospective experience. Circulation 2003 107:93 97.